FundedIQ
Biotechnology

Artio Medical: Funding, Investors & Team (Oct 2026)

Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures. The company's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. These products enable physicians to perform better, faster, and safer vascular occlusion procedures. The company was founded in 2011 and is based in Olathe, Kansas.

artiomedical.com LinkedIn Olathe, United States 11-50 employees
Biotechnology Health Care Medical Medical Device
Total raised
$39.4M
Rounds
2
Latest
Series A
Jun 2022

Artio Medical has raised $39.4M across 2 funding rounds on record, the most recent a Series A of $28.0M announced in Jun 2022.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Artio Medical Company Profile and Key Stats

Total funding raised
$39.4M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series A
$28.0M in Jun 2022
Employees
11-50
reported band
Headquarters
Olathe, United States

Latest funding round on record: Jun 2022.

Artio Medical Funding Rounds

Date
Round
Amount
Series A
$28.0M
Undisclosed round
$11.4M

Artio Medical raised $11.4M in an undisclosed round announced in Feb 2022.

4 months later, a Series A of $28.0M was announced in Jun 2022.

Artio Medical Founders and Leadership Team

Name
Role
Contact
Nicholas Franano
CEO
Locked

Contact details for the Artio Medical team: 1 of 1 has an email address on file.

Start 14-day free trial →

Artio Medical Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
8,591
$15M

Artio Medical's latest round of $28.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Artio Medical in Biotechnology and Olathe

Companies Similar to Artio Medical

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Artio Medical Funding FAQs

What does Artio Medical do?

Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures. The company's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform. These products enable physicians to perform better, faster, and safer vascular occlusion procedures. The company was founded in 2011 and is based in Olathe, Kansas.

How much funding has Artio Medical raised?

Artio Medical has raised $39.4M across 2 rounds on record. The most recent is a Series A of $28.0M announced in Jun 2022.

When did Artio Medical last raise funding?

Artio Medical's most recent funding round on record is a Series A of $28.0M, announced in Jun 2022.

Who is the CEO of Artio Medical?

Nicholas Franano is listed as CEO at Artio Medical.

Where is Artio Medical headquartered?

Artio Medical is based in Olathe, Kansas, United States.

How many employees does Artio Medical have?

Artio Medical is in the 11-50 employee band.

How does Artio Medical's funding compare to other Biotechnology startups?

Artio Medical's latest round of $28.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Artio Medical Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Artio Medical is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.